
Using AI and Longitudinal Data to Transform Rare Disease Care
May 7, 2026 - 00:19:21
Radio and PodcastLive Radio & Podcasts
When Jim Foote lost his son, Trey, to osteosarcoma, it exposed the limits of one-size-fits-all cancer protocols. He co-founded First Ascent Biomedical to apply functional precision medicine to rare and pediatric cancers....
Matching the Right Therapy to the Right Child with a Rare Cancer is an episode from RARECast by RARECast. When Jim Foote lost his son, Trey, to osteosarcoma, it exposed the limits of one-size-fits-all cancer protocols. He co-founded First A...
This episode belongs to RARECast.
Use the player on this page to stream the episode online.
Published Apr 16, 2026, 00:45:47 long, audio available.